Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis
- PMID: 18474740
- DOI: 10.1001/archneur.65.5.636
Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis
Abstract
Background: Pathological 43-kDa transactivating responsive sequence DNA-binding protein (TDP-43) has been identified recently as the major disease protein in amyotrophic lateral sclerosis (ALS), and in frontotemporal lobar degeneration with ubiquitinated inclusions, with or without motor neuron disease, but the distribution of TDP-43 pathology in ALS may be more widespread than previously described.
Objective: To determine the extent of TDP-43 pathology in the central nervous systems of patients with clinically confirmed and autopsy confirmed diagnoses of ALS.
Design: Performance of an immunohistochemical whole-central nervous system scan for evidence of pathological TDP-43 in ALS patients.
Setting: An academic medical center.
Participants: We included 31 patients with clinically and pathologically confirmed ALS and 8 control participants.
Main outcome measures: Immunohistochemistry and double-labeling immunofluorescence to assess the frequency and severity of TDP-43 pathology.
Results: In addition to the stereotypical involvement of upper and lower motor neurons, neuronal and glial TDP-43 pathology was present in multiple areas of the central nervous systems of ALS patients, including in the nigro-striatal system, the neocortical and allocortical areas, and the cerebellum, but not in those of the controls.
Conclusions: These findings suggest that ALS does not selectively affect only the pyramidal motor system, but rather is a multisystem neurodegenerative TDP-43 proteinopathy.
Similar articles
-
Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).Neuropathol Appl Neurobiol. 2015 Aug;41(5):578-97. doi: 10.1111/nan.12206. Epub 2015 Apr 20. Neuropathol Appl Neurobiol. 2015. PMID: 25487060 Review.
-
[Clinical and pathological spectrum of TDP-43 associated ALS].Rinsho Shinkeigaku. 2010 Nov;50(11):940-2. doi: 10.5692/clinicalneurol.50.940. Rinsho Shinkeigaku. 2010. PMID: 21921519 Review. Japanese.
-
Clinical and pathological continuum of multisystem TDP-43 proteinopathies.Arch Neurol. 2009 Feb;66(2):180-9. doi: 10.1001/archneurol.2008.558. Arch Neurol. 2009. PMID: 19204154 Free PMC article.
-
Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.Acta Neuropathol. 2008 Jan;115(1):123-31. doi: 10.1007/s00401-007-0315-5. Epub 2007 Nov 15. Acta Neuropathol. 2008. PMID: 18004574
-
TDP-43 in differential diagnosis of motor neuron disorders.Acta Neuropathol. 2007 Jul;114(1):71-9. doi: 10.1007/s00401-007-0234-5. Epub 2007 Jun 14. Acta Neuropathol. 2007. PMID: 17569066
Cited by
-
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases.Nat Rev Neurosci. 2024 May;25(5):351-371. doi: 10.1038/s41583-024-00806-0. Epub 2024 Apr 4. Nat Rev Neurosci. 2024. PMID: 38575768 Review.
-
Impairment of oculomotor functions in patients with early to advanced amyotrophic lateral sclerosis.J Neurol. 2024 Jan;271(1):325-339. doi: 10.1007/s00415-023-11957-y. Epub 2023 Sep 15. J Neurol. 2024. PMID: 37713127 Free PMC article.
-
Mature iPSC-derived astrocytes of an ALS/FTD patient carrying the TDP43A90V mutation display a mild reactive state and release polyP toxic to motoneurons.Front Cell Dev Biol. 2023 Jul 28;11:1226604. doi: 10.3389/fcell.2023.1226604. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37645251 Free PMC article.
-
Specific vulnerability of iPSC-derived motor neurons with TDP-43 gene mutation to oxidative stress.Mol Brain. 2023 Jul 26;16(1):62. doi: 10.1186/s13041-023-01050-w. Mol Brain. 2023. PMID: 37496071 Free PMC article.
-
Psychotic symptoms in frontotemporal dementia with TDP-43 tend to be associated with type B pathology.Neuropathol Appl Neurobiol. 2023 Aug;49(4):e12921. doi: 10.1111/nan.12921. Neuropathol Appl Neurobiol. 2023. PMID: 37386798
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous